• Complix and VIB publish pioneering study on Cell-Penetrating Alphabodies in Science Advances

    Wednesday March 31st 2021

  • Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer

    Wednesday March 31st 2021

  • Richter and Mithra receive positive CHMP opinion for Estelle®

    Monday March 29th 2021

  • Galapagos appoints Bart Filius as President and Chief Operating Officer

    Thursday March 25th 2021

  • Biotalys files its first protein-based biocontrol for registration in the EU

    Thursday March 25th 2021

  • Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases

    Tuesday March 23rd 2021

  • ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version

    Monday March 22nd 2021

  • Biocartis launches Idylla™ GeneFusion Assay as rapid lab workflow solution for gene fusion testing

    Monday March 22nd 2021

  • Your news here?

  • Consortium led by eTheRNA immunotherapies awarded EU Commission TIGER Grant of EUR 6.9 million

    Sunday March 21st 2021

  • Augustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board

    Friday March 19th 2021

  • reMYND appoints Dr. Lode Debrabandere as Chief Business Officer

    Thursday March 18th 2021


Strategic Partners